  Non-invasive ambulatory estimation of blood oxygen saturation has emerged as
an important clinical requirement to detect hypoxemia in the delayed
post-infective phase of COVID-19, where dangerous hypoxia may occur in the
absence of subjective breathlessness. This immediate clinical driver, combined
with the general quest for more personalised health data, means that pulse
oximetry measurement of capillary oxygen saturation (SpO2) will likely expand
into both the clinical and consumer market of wearable health technology in the
near future. In this study, we set out to establish the feasibility of SpO2
measurement from the ear canal as a convenient site for long term monitoring,
and perform a comprehensive comparison with the right index finger - the
conventional clinical measurement site. During resting SpO2 estimation, we
found a root mean square difference of 1.47% between the two measurement sites,
with a mean difference of 0.23% higher SpO2 in the right ear canal. Through the
simultaneous recording of pulse oximetry from both the right ear canal and
index finger during breath holds, we observe a substantial improvement in
response time between the ear and finger that has a mean of 12.4 seconds and a
range of 4.2 - 24.2 seconds across all subjects. Factors which influence this
response time, termed SpO2 delay, such as the sex of a subject are also
explored. Furthermore, we examine the potential downsides of ear canal blood
oxygen saturation measurement, namely the lower photoplethysmogram amplitude,
and suggest ways to mitigate this disadvantage. These results are presented in
conjunction with previously discovered benefits such as robustness to
temperature, making the case for measurement of SpO2 from the ear canal being
both convenient and superior to conventional finger measurement sites for
continuous non-intrusive long term monitoring in both clinical and
everyday-life settings.
